Efficacy and Safety Study of TLC388 to Advanced Hepatocellular Carcinoma

NCT02267213 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
29
Enrollment
INDUSTRY
Sponsor class

Stopped Current study design couldn't support futher development on this indication

Conditions

Interventions

Sponsor

Taiwan Liposome Company